Table 4.
Summary of hospitalization
| Hospitalization data | Controls (n = 89) | Vitamin K2 (n = 89) | Effect measurea (95% CI) | P-value |
|---|---|---|---|---|
| Total patients with hospitalization | 60 | 54 | 0.90 (0.72–1.12) | 0.35 |
| Average hospitalizations per patient | 1 | 2 | 1.27 (0.90–1.80) | 0.18 |
| Total hospitalizations | 133 | 169 | ||
| Categories of hospitalization | ||||
| Infection | 55 | 79 | ||
| Fluid overload | 11 | 13 | ||
| Gastrointestinal-related | 20 | 14 | ||
| Cardiac-relatedb | 4 | 4 | ||
| Others | 43 | 59 |
a
The effect measure refers to relative risk for total patients with hospitalization, and incidence rate ratio for average hospitalizations per patient.
b
Refers to non-MACE cardiac-related events.